Stage four pancreatic cancer is the most advanced stage, where cancer has spread beyond the pancreas to distant organs like the liver, lungs, or peritoneum. This stage is also called metastatic pancreatic cancer.
The American Cancer Society explains that pancreatic cancer progresses through four stages. Stage four is unique because the cancer has metastasized, making it incurable with current treatments. Unlike earlier stages, where surgery may still be an option, stage four focuses on managing symptoms and extending life expectancy.
Stage four pancreatic cancer is characterized by:
Symptoms of stage four pancreatic cancer often include severe pain, weight loss, jaundice, and fatigue. These symptoms occur as the cancer affects nearby organs and disrupts their function. For example, jaundice develops when a tumor blocks the bile duct, preventing bile from reaching the intestines.
Treatment for stage four pancreatic cancer typically involves chemotherapy, radiation therapy, targeted therapy, or immunotherapy. These treatments aim to shrink tumors, relieve symptoms, and prolong life. Clinical trials may also offer access to experimental therapies.
For instance, a common chemotherapy regimen includes drugs like gemcitabine or FOLFIRINOX, which can help manage the disease and improve quality of life. Palliative care focuses on pain management and symptom relief.
The National Cancer Institute reports that the five-year relative survival rate for stage four pancreatic cancer is about 3%. However, survival rates can vary based on individual factors like health and response to treatment.
While stage four pancreatic cancer is often terminal, advancements in treatment continue to improve outcomes. Supportive care is important for maintaining comfort and quality of life.
To understand what stage four means in general, see what stage four cancer means.